About VenoStent
VenoStent is a company based in Nashville (United States) founded in 2017. VenoStent has raised $23.36 million across 11 funding rounds from investors including NIH, HHS and Norwest Venture Partners. VenoStent offers products and services including SelfWrap. VenoStent operates in a competitive market with competitors including Invizius, Renal Solutions, Redsense Medical, Doto Medical and Health Line International Corporation, among others.
- Headquarter Nashville, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Venostent, Inc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$23.36 M (USD)
in 11 rounds
-
Latest Funding Round
Not available
-
Investors
NIH
& 16 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of VenoStent
VenoStent offers a comprehensive portfolio of products and services, including SelfWrap.
Bioabsorbable wrap designed to prevent failures in dialysis access sites.
People of VenoStent
Unlock access to complete
Unlock access to complete
Funding Insights of VenoStent
VenoStent has successfully raised a total of $23.36M across 11 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in VenoStent
VenoStent has secured backing from 17 investors, including institutional and venture fund investors. Prominent investors backing the company include NIH, HHS and Norwest Venture Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital and growth equity firm providing investments and resources to entrepreneurs in various sectors.
|
Locked | Locked | Locked | |
|
Early-stage investments are made in life sciences and technologies.
|
Locked | Locked | Locked | |
|
Venture capital investments are provided by IAG Capital Partners.
|
Locked | Locked | Locked |
Investor details for VenoStent
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by VenoStent
Investment portfolio details for VenoStent
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - VenoStent
Detailed financials for VenoStent
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Venostent Comparisons
Peer comparison for VenoStent
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of VenoStent
VenoStent operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Invizius, Renal Solutions, Redsense Medical, Doto Medical and Health Line International Corporation, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Priming solutions for hemodialyzers are developed to reduce blood reactions.
|
|
| Locked | Locked | Locked |
Sorbents for renal replacement therapy are developed using regenerative technology.
|
|
| Locked | Locked | Locked |
Blood access is monitored during hemodialysis via alarm systems.
|
|
| Locked | Locked | Locked |
Develops medical devices to enhance hemodialysis and treat kidney disease.
|
|
| Locked | Locked | Locked |
Contract Manufacturer of Dialysis products, Also sells own product lines.
|
Detailed competitors of VenoStent
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Venostent
Complete news archive for VenoStent
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about VenoStent
VenoStent was founded in 2017 and raised its 1st funding round 1 year after it was founded.
VenoStent is headquartered in Nashville, United States. It is registered at Nashville, Tennessee, United States.
Timothy Boire is the current CEO of VenoStent.
VenoStent is a funded company, having raised a total of $23.36M across 11 funding rounds to date.
VenoStent was founded in 2017 and is based in Nashville, United States. The company operates in the medical device sector, focusing on vascular surgery solutions. A shape memory polymer stent, known as SelfWrap, is developed as an external wrap for venous access in hemodialysis patients. Mechanical support is provided to reduce vein collapse and promote vein growth at surgical sites.
VenoStent's top competitors include Invizius, Redsense Medical and Renal Solutions.
VenoStent offers SelfWrap.
VenoStent has 17 investors. Key investors include NIH, HHS, Norwest Venture Partners, Good Growth Capital, and IAG Capital Partners.